Acceligen Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Acceligen General Information

Description

Developer of precision breeding technology intended to improve animal welfare and resist diseases. The company specializes in precisely delivering traits based on gene editing technology and introduces unique and valuable genetics to dramatically shorten the development cycles typical with conventional selective breeding, empowering animal breeders with new opportunities to accelerate genetic improvement.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3388 Mike Collins Drive
  • Eagan, MN 55121
  • United States
+1 (612)
Primary Industry
Biotechnology
Other Industries
Animal Husbandry
Other Agriculture
Parent Company
Vertical(s)
Corporate Office
  • 3388 Mike Collins Drive
  • Eagan, MN 55121
  • United States
+1 (612)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acceligen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Acceligen‘s full profile, request access.

Request a free trial

Acceligen Patents

Acceligen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015320738-A1 Materials and methods for producing animals with short hair Active 23-Sep-2014
AU-2015320738-B2 Materials and methods for producing animals with short hair Active 23-Sep-2014
AU-2022201249-A1 Materials and methods for producing animals with short hair Inactive 23-Sep-2014
US-20150018604-A1 Methods for spermatogonial stem cell (ssc) transfer Active 13-Jul-2013
US-20170231737-A1 Methods for spermatogonial stem cell (ssc) transfer Inactive 13-Jul-2013 A61D19/00
To view Acceligen’s complete patent history, request access »

Acceligen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acceligen Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Acceligen‘s full profile, request access.

Request a free trial

Acceligen FAQs

  • When was Acceligen founded?

    Acceligen was founded in 2014.

  • Where is Acceligen headquartered?

    Acceligen is headquartered in Eagan, MN.

  • What is the size of Acceligen?

    Acceligen has 4 total employees.

  • What industry is Acceligen in?

    Acceligen’s primary industry is Biotechnology.

  • Is Acceligen a private or public company?

    Acceligen is a Private company.

  • What is Acceligen’s current revenue?

    The current revenue for Acceligen is .

  • Who are Acceligen’s investors?

    Recombinetics has invested in Acceligen.

  • When was Acceligen acquired?

    Acceligen was acquired on 08-Jan-2025.

  • Who acquired Acceligen?

    Acceligen was acquired by Trans Ova Genetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process